Macrolide Immunosuppressive Therapy for Pregnancy Tolerance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapeutic methods for infecundity and infertilitas are inadequate, particularly for cases with unclear causes, and existing immunosuppressive therapies like steroid and gamma-globulin therapy have undesirable side effects and risks, while the immune mechanism changes during pregnancy are not fully understood.
Innovation Solution
A medicine comprising a macrolide-based compound, such as tacrolimus, is used to suppress immune responses and promote immunological tolerance, ameliorating pregnancy conditions like sterility, infertility, and complications like HELLP syndrome.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If steroid therapy or large-quantity gamma-globulin therapy is used to treat infertilitas, then immune suppression is achieved, but undesirable side effects and risks occur
Solution Approach 1:
The patent changes the parameter of immunosuppressive agent from conventional steroids and gamma-globulin to a specific macrolide compound (Formula I) with modified chemical structure. This parameter change achieves effective immune suppression while reducing harmful side effects through the novel compound's unique pharmacological properties.
Solution Approach 2:
The patent employs a novel macrolide compound that can be administered in controlled, limited doses for specific treatment periods. This approach uses a targeted, temporary immunosuppressive agent rather than long-term conventional therapies, reducing cumulative side effects while maintaining treatment effectiveness.
2Adaptability or versatility
If conventional therapeutic methods are used for infecundity and infertilitas with unclear causes, then treatment is attempted, but adequate results are not achieved
Solution Approach 1:
The patent develops a universal therapeutic approach using the macrolide compound (Formula I) that can be applied to various forms of infertilitas and infecundity regardless of identified cause. The compound's broad-spectrum immunosuppressive and immunomodulatory properties enable it to address different pathophysiological mechanisms underlying reproductive disorders.
Solution Approach 2:
The patent incorporates monitoring of pregnancy status and immune parameters to adjust treatment dosage and duration. This feedback mechanism allows optimization of treatment effectiveness for cases with unclear causes by adapting therapy to individual patient responses and progression.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The medicine effectively ameliorates pregnancy conditions by suppressing immune rejection reactions against fertilized ova or fetuses, reducing side effects, and prolonging pregnancy, while also addressing complications like HELLP syndrome.
Implementation Method 1
A medicine comprising a macrolide-based compound, such as tacrolimus, is used to suppress immune responses and promote immunological tolerance
Data Source
AI summary
A medicine for improving the state of pregnancy, which contains a compound of general formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient; and a use of the medicine: